Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 8.01
-0.09 (-1.11%)
At close: Mar 26, 2026
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 3.35 billion as of March 26, 2026. Its market cap has decreased by -53.61% in one year.
Market Cap
3.35B
Enterprise Value
3.20B
Revenue
246.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.01
Market Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 3.35B, a decrease of -34.33%. That is a compound annual growth rate of -12.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 3.35B | -3.49% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Laboratories | 6.54B |
| Orient Pharma | 6.38B |
| SCI Pharmtech | 6.30B |
| LIWANLI Innovation | 5.24B |
| Easywell Biomedicals | 4.84B |
| Orient EuroPharma | 4.00B |
| Maywufa Company | 2.90B |
| Allied Biotech | 2.62B |